TY - JOUR
T1 - Antiproliferative Hybrid Analogs of the Hormone 1α,25-Dihydroxyvitamin D3
T2 - Design, Synthesis, and Preliminary Biological Evaluation
AU - Posner, Gary H.
AU - Lee, Jae Kyoo
AU - White, M. Christina
AU - Hutchings, Richard H.
AU - Dai, Haiyan
AU - Kachinski, Joseph L.
AU - Dolan, Patrick
AU - Kensler, Thomas W.
PY - 1997
Y1 - 1997
N2 - The combination of 10-12 kbar pressure plus Lewis acidic zinc dichloride promotes highly regioselective and stereoselective Diels - Alder cycloaddition between 3-bromo-2-pyrone, prepared in a new way, and unactivated terminal alkene 4-(tert-butyldimethylsiloxy)-1-butene. The conjugate base of A-ring allylic phosphine oxide 20 adds chemospecifically to the C-8 keto group of some C-8,C-24-diketones to form directly metabolically resistant 24-oxo analogs of 1α,25-dihydroxyvitamin D3 (calcitriol). Several of these new hybrid analogs are as efficacious in vitro as calcitriol at inhibiting growth of murine keratinocytes even at physiologically relevant 10-100 nanomolar concentrations.
AB - The combination of 10-12 kbar pressure plus Lewis acidic zinc dichloride promotes highly regioselective and stereoselective Diels - Alder cycloaddition between 3-bromo-2-pyrone, prepared in a new way, and unactivated terminal alkene 4-(tert-butyldimethylsiloxy)-1-butene. The conjugate base of A-ring allylic phosphine oxide 20 adds chemospecifically to the C-8 keto group of some C-8,C-24-diketones to form directly metabolically resistant 24-oxo analogs of 1α,25-dihydroxyvitamin D3 (calcitriol). Several of these new hybrid analogs are as efficacious in vitro as calcitriol at inhibiting growth of murine keratinocytes even at physiologically relevant 10-100 nanomolar concentrations.
UR - http://www.scopus.com/inward/record.url?scp=1542398461&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542398461&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:1542398461
SN - 0022-3263
VL - 62
SP - 3291
EP - 3298
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 10
ER -